09:55 duration 9 minutes 55 seconds
VALOR- HCM Shows Promise for Patients with…
VALOR- HCM Shows Promise for Patients with Symptomatic Hypertrophic Cardiomyopathy
Presented at ACC as a Late-Breaking Clinical Trial, VALOR-HCM explores Mavacamten as an alternative to surgical septal myectomy or alcohol ablation in patients with severely symptomatic obstructive…